202 related articles for article (PubMed ID: 18227490)
21. Prevention of cardiovascular events in diabetes.
Sigal R; Malcolm J; Arnaout A
Clin Evid; 2006 Jun; (15):623-45. PubMed ID: 16973029
[No Abstract] [Full Text] [Related]
22. [The polypill: optimal strategy for reduction of cardiovascular disease].
Nathoe HM; Doevendans PA
Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1740. PubMed ID: 16114290
[TBL] [Abstract][Full Text] [Related]
23. [Should one prescribe aspirin for all diabetics?].
Passa P
Diabetes Metab; 1997 Dec; 23(6):554-6. PubMed ID: 9496565
[No Abstract] [Full Text] [Related]
24. [The vascular risk in the diabetic: the lipid factor, from epidemiologic data to intervention trials].
Moulin P
Diabetes Metab; 1999 Jun; 25 Suppl 3():41-5. PubMed ID: 10421992
[TBL] [Abstract][Full Text] [Related]
25. The concept of the polypill in the prevention of cardiovascular disease.
Wiley B; Fuster V
Ann Glob Health; 2014; 80(1):24-34. PubMed ID: 24751562
[TBL] [Abstract][Full Text] [Related]
26. The future of metabolic syndrome and cardiovascular disease prevention: polyhype or polyhope? Tales from the polyera.
Franco OH; Karnik K; Bonneux L
Horm Metab Res; 2007 Sep; 39(9):627-31. PubMed ID: 17846968
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
[TBL] [Abstract][Full Text] [Related]
28. Long-term adherence to statin treatment in diabetes.
Donnelly LA; Doney AS; Morris AD; Palmer CN; Donnan PT
Diabet Med; 2008 Jul; 25(7):850-5. PubMed ID: 18644071
[TBL] [Abstract][Full Text] [Related]
29. Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.
Tsang JL; Mendelsohn A; Tan MK; Hackam DG; Leiter LA; Fitchett D; Lin PJ; Grima E; Langer A; Goodman SG;
Am J Cardiol; 2008 Nov; 102(9):1142-5. PubMed ID: 18940280
[TBL] [Abstract][Full Text] [Related]
30. Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.
Younis N; Williams S; Soran H
Diabetes Obes Metab; 2009 Nov; 11(11):997-1000. PubMed ID: 19531055
[TBL] [Abstract][Full Text] [Related]
31. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
[TBL] [Abstract][Full Text] [Related]
32. [The polypill as cardiovascular prophylactic: clinical trials].
Sandli OK; Spigset O; Slørdal L
Tidsskr Nor Laegeforen; 2014 Mar; 134(6):620-3. PubMed ID: 24670510
[TBL] [Abstract][Full Text] [Related]
33. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
[TBL] [Abstract][Full Text] [Related]
34. Aspirin response and failure in diabetic patients with cardiovascular disease.
Yan Y; Phillips DR
Curr Opin Pharmacol; 2005 Apr; 5(2):190-7. PubMed ID: 15780830
[TBL] [Abstract][Full Text] [Related]
35. Statin therapy in patients with type 2 diabetes.
Lo V; Noviasky J; Nashelsky J
Am Fam Physician; 2005 Sep; 72(5):866-8. PubMed ID: 16156346
[No Abstract] [Full Text] [Related]
36. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
Staels B; Maes M; Zambon A
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
[TBL] [Abstract][Full Text] [Related]
37. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):34L-40L. PubMed ID: 19084088
[TBL] [Abstract][Full Text] [Related]
38. Polypill in cardiovascular disease: has it's time come?
Kuppuswamy V; Choo WK; Gupta S
Indian Heart J; 2009; 61(4):322-7. PubMed ID: 20635733
[No Abstract] [Full Text] [Related]
39. Statin power.
Diabetes Forecast; 2008 Apr; 61(4):28. PubMed ID: 18478640
[No Abstract] [Full Text] [Related]
40. Achieving vascular risk factor targets: a survey of a London general practice.
Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
